MarketCap
Facebook
X
Telegram
Country |
 Cayman-islands |
IPO year |
2016 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
1.42 B |
Market Cap[1] |
$ 251 B |
EBITDA (LTM) |
$ 1.21 B |
P/E (LTM) |
- |
P/S (LTM) |
37.941131 |
EPS (LTM) |
0.62 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Alterity Therapeutics Limited
ATHE
|
$ 2.3 | -5.35 % | $ 14.7 B | Nasdaq Capital Market |  Australia |
 |
Shineco, Inc.
TYHT
|
- | -3.90 % | $ 97.2 M | Nasdaq Global Select Market |  China |
 |
Millendo Therapeutics, Inc.
MLND
|
- | -5.36 % | $ 20.2 M | Nasdaq Global Select Market |  USA |
 |
Certara
CERT
|
$ 12.21 | -0.08 % | $ 1.96 B | Nasdaq Global Select Market | USA |
 |
Dyadic International
DYAI
|
$ 0.39 | 1.16 % | $ 14.1 M | Nasdaq Capital Market | USA |
 |
Intec Pharma Ltd
NTEC
|
- | -12.45 % | $ 17.7 M | Nasdaq Capital Market |  Israel |
 |
Anika Therapeutics
ANIK
|
$ 13.42 | -7.89 % | $ 192 M | Nasdaq Global Select Market,SPB | USA |
 |
Aprea Therapeutics
APRE
|
$ 0.45 | -9.44 % | $ 2.94 M | Nasdaq Global Select Market,SPB | USA |
 |
Galectin Therapeutics
GALT
|
$ 3.4 | -1.73 % | $ 217 M | Nasdaq Global Select Market | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
$ 73.22 | -2.41 % | $ 7.6 B | Nasdaq Capital Market,SPB | USA |
 |
Progenity, Inc.
PROG
|
- | -3.47 % | $ 164 M | Nasdaq Global Select Market | USA |
 |
Genprex
GNPX
|
$ 2.1 | 1.94 % | $ 1.96 M | Nasdaq Capital Market | USA |
 |
Strongbridge Biopharma plc
SBBP
|
- | 1.52 % | $ 136 M | Nasdaq Global Select Market | USA |
 |
Innate Pharma S.A.
IPHA
|
$ 1.54 | 1.98 % | $ 138 M | Nasdaq Global Select Market |  France |
 |
Seneca Biopharma, Inc.
SNCA
|
- | -1.19 % | $ 28.7 M | Nasdaq Capital Market | USA |
 |
BioMarin Pharmaceutical
BMRN
|
$ 57.1 | -0.14 % | $ 11 B | Nasdaq Global Select Market,SPB | USA |
 |
Matinas BioPharma Holdings
MTNB
|
$ 1.19 | -4.03 % | $ 6.51 M | NYSE American | USA |
 |
Enanta Pharmaceuticals
ENTA
|
$ 11.24 | -2.01 % | $ 240 K | Nasdaq Global Select Market,SPB | USA |
 |
SIGA Technologies
SIGA
|
$ 3.14 | -3.83 % | $ 225 M | Nasdaq Global Select Market | USA |
 |
Milestone Pharmaceuticals
MIST
|
$ 0.68 | -7.49 % | $ 72.2 M | Nasdaq Global Select Market |  Canada |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 94.9 | -3.91 % | $ 7.04 B | Nasdaq Global Select Market | USA |
 |
Lipocine
LPCN
|
$ 1.59 | -7.85 % | $ 8.66 M | Nasdaq Global Select Market | USA |
 |
PTC Therapeutics
PTCT
|
$ 64.12 | -1.4 % | $ 5.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Seres Therapeutics
MCRB
|
$ 1.55 | -8.75 % | $ 13.7 M | Nasdaq Global Select Market | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
$ 432.48 | -0.07 % | $ 9.7 B | Nasdaq Global Select Market,SPB | USA |
 |
CEL-SCI Corporation
CVM
|
$ 1.41 | 4.07 % | $ 11.3 M | NYSE American,SPB | USA |
 |
Inventiva S.A.
IVA
|
$ 3.95 | 2.73 % | $ 236 M | Nasdaq Global Market | France |
 |
MeiraGTx Holdings plc
MGTX
|
$ 9.62 | 1.37 % | $ 774 M | Nasdaq Global Select Market | USA |
 |
Processa Pharmaceuticals
PCSA
|
$ 1.86 | -4.62 % | $ 2.44 M | Nasdaq Global Select Market | USA |
 |
Eton Pharmaceuticals
ETON
|
$ 67.5 | 4.9 % | $ 1.82 B | Nasdaq Global Market | USA |
 |
IDEAYA Biosciences
IDYA
|
$ 31.72 | -0.97 % | $ 2.81 B | Nasdaq Global Select Market | USA |
 |
Protalix BioTherapeutics
PLX
|
$ 2.86 | 11.28 % | $ 225 M | NYSE American | Israel |
 |
Lantern Pharma
LTRN
|
$ 0.47 | -22.86 % | $ 5.12 M | Nasdaq Global Select Market | USA |
 |
Foghorn Therapeutics
FHTX
|
$ 1.89 | -7.35 % | $ 119 M | Nasdaq Global Market | USA |
 |
Ocugen
OCGN
|
$ 0.95 | -2.45 % | $ 297 M | Nasdaq Capital Market | USA |
 |
Oncolytics Biotech
ONCY
|
$ 0.38 | -5.64 % | $ 36.4 M | Nasdaq Global Select Market | Canada |
 |
Minerva Neurosciences
NERV
|
$ 2.47 | -6.08 % | $ 20.9 M | Nasdaq Global Market | USA |
 |
Kamada Ltd.
KMDA
|
$ 8.09 | 4.93 % | $ 466 M | Nasdaq Global Select Market | Israel |
 |
Neurocrine Biosciences
NBIX
|
$ 169.08 | 0.13 % | $ 16.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 32.8 | 2.4 % | $ 1.57 T | Nasdaq Global Select Market | France |
 |
Mereo BioPharma Group plc
MREO
|
$ 0.3 | 1.66 % | $ 239 M | Nasdaq Global Select Market |  Britain |
 |
Maravai LifeSciences Holdings
MRVI
|
$ 7.86 | -2.31 % | $ 1.13 B | Nasdaq Global Select Market | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
$ 1.84 | 0.82 % | $ 668 M | Nasdaq Global Select Market | USA |
 |
Moleculin Biotech
MBRX
|
$ 8.01 | -7.51 % | $ 9.49 M | Nasdaq Global Select Market | USA |
 |
Nurix Therapeutics
NRIX
|
$ 15.89 | -1.58 % | $ 1.38 B | Nasdaq Global Select Market,SPB | USA |
 |
Nkarta
NKTX
|
$ 1.36 | -14.78 % | $ 101 M | Nasdaq Global Select Market | USA |
 |
MacroGenics
MGNX
|
$ 2.42 | 3.42 % | $ 153 M | Nasdaq Global Select Market | USA |
 |
Protagonist Therapeutics
PTGX
|
$ 136.18 | 0.2 % | $ 8.66 B | Nasdaq Global Select Market | USA |
|
Nuvation Bio
NUVB
|
$ 4.22 | -3.1 % | $ 1.44 B | NYSE | USA |
 |
Novo Nordisk A/S
NVO
|
$ 40.6 | -1.88 % | $ 180 B | NYSE |  Danmark |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.